NCT02328547View on ClinicalTrials.gov

Fecal Microbiota Transplantation for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

October 31, 2017

Study Completion Date

March 31, 2018

Conditions
Irritable Bowel Syndrome
Interventions
DRUG

Fecal microbiota transplantation capsules

Fecal microbiota transplantation capsules contain extensively screened donor stool and are prepared by OpenBiome, Medford, MA.

DRUG

Placebo capsules

Placebo capsules prepared by OpenBiome, Medford, MA

Trial Locations (3)

10016

Concorde Medical Group, New York

10467

Montefiore Medical Center, The Bronx

06518

Medical Research Center of Connecticut, Hamden

All Listed Sponsors
lead

Montefiore Medical Center

OTHER

NCT02328547 - Fecal Microbiota Transplantation for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome | Biotech Hunter | Biotech Hunter